The entity also holds 6,743,321 shares of non-voting common stock, which are convertible into common stock. Apogee, with a market capitalization of approximately $5.5 billion, holds more cash than ...
Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift in biologic treatment for inflammatory diseases. APGE's $913 million cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results